U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Vaccines, Blood & Biologics
  3. Geenius HIV 1/2 Supplemental Assay (BL 125670)
  1. Vaccines, Blood & Biologics

Geenius HIV 1/2 Supplemental Assay (BL 125670)

STN: 125670
Proper Name: Human Immunodeficiency Virus Types 1 and 2 (Recombinant and Synthetic Peptides)
Tradename: Geenius HIV 1/2 Supplemental Assay
Manufacturer: Bio-Rad Laboratories, Inc.
Indication:

  • The Geenius HIV 1/2 Supplemental Assay is a single-use immunochromatographic assay for the confirmation and differentiation of individual antibodies to Human Immunodeficiency Virus Types 1 and 2 (HIV-1 and HIV-2) in serum, or plasma samples, lithium heparin, sodium citrate, and CPD) from blood donors.
  • The Geenius HIV 1/2 Supplemental Assay is intended for use as an additional, more specific test for human serum and plasma samples with repeatedly reactive results by an FDA licensed blood donor screening test for antibodies to HIV‑1/HIV‑2.The results of the Geenius HIV 1/2 Supplemental Assay are read and interpreted only with the Geenius. Reader with dedicated software.

Product Information

Supporting Documents

Back to Top